Progress and Deficiencies in the Registration of Clinical Trials | NEJM
Progress and Deficiencies in the Registration of Clinical Trials | NEJM
Trial registration, publication rate and characteristics in the research field of otology: A cross-sectional study | PLOS ONE
ACER-801 100 mg BID for Postmenopausal Vasomotor Symptoms Clinical Trial | Power
First Action for Non-Compliance with FDAAA section 801 Requirements
What you Need and When – The Key Documents in the Drug Lifecycle - Trilogy Writing & Consulting GmbH
Clinical Trial Registries.
Transparency on trial: How to navigate FDAAA 801 final rule implementation and compliance
alt-ex991_6.htm
FOCUS ON NLM RESOURCES: CLINICALTRIALS.GOV. WHAT IS A CLINICAL STUDY? Research study using human subjects. Volunteers may have a certain disease or. - ppt download
Underlying Clinical Data - Alzheon | Preserving Future Memories
Acer Therapeutics Enrolls First Patient in its Phase 2a Clinical Trial of ACER-801 for Treatment of Moderate to Severe Vasomotor Symptoms Associated with Menopause
10-Year Update on Study Results Submitted to ClinicalTrials.gov | NEJM
Requirements for Registering & Reporting NIH-funded Clinical Trials in ClinicalTrials.gov | grants.nih.gov
VTX-801 Receives U.S. FDA Fast Track Designation for the Treatment of Wilson Disease | Pfizer
Clinical Trial Registration & Results Disclosure Requirements | FDAAA801
FDAAA 801 and the Final Rule - ClinicalTrials.gov
Clinical Trial Results Transparency and the Changing Paradigm of Medi…
IJMS | Free Full-Text | Neurotoxic Soluble Amyloid Oligomers Drive Alzheimer's Pathogenesis and Represent a Clinically Validated Target for Slowing Disease Progression | HTML
Clinical trials for pancreatic cancer - Pancreatic Cancer UK
FAQS and facts about clinical trials and ethical errors - Journal of Plastic, Reconstructive & Aesthetic Surgery
Transparency on trial: How to navigate FDAAA 801 final rule implementation and compliance
